2.2. Study Design and Participants
RECRUITMENT
This study was carried out at the Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark, spanning the period from December 2020 to April 2022. The study adhered to the principles outlined in the Declaration of Helsinki and received approval from The Central Denmark Region Committees on Health Research Ethics (Journal no. 1-10-72-102-19). Furthermore, the study was enlisted on Advertisements in local newspapers, a dedicated recruitment website (“Pre and post each supplementation period, we assessed 24 h ambulatory blood pressure and took fasting blood samples to quantify lipids, adiponectin, and hs-CRP levels.